Acorah Software Products - Accounts Production 16.1.200 false true false true No description of principal activity 8 November 2023 30 November 2024 30 November 2024 NI704441 Dr Peter Quinn iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure NI704441 2023-11-07 NI704441 2024-11-30 NI704441 2023-11-08 2024-11-30 NI704441 frs-core:CurrentFinancialInstruments 2024-11-30 NI704441 frs-bus:PrivateLimitedCompanyLtd 2023-11-08 2024-11-30 NI704441 frs-bus:FilletedAccounts 2023-11-08 2024-11-30 NI704441 frs-bus:Micro-entities 2023-11-08 2024-11-30 NI704441 frs-bus:AuditExempt-NoAccountantsReport 2023-11-08 2024-11-30 NI704441 frs-bus:Director1 2023-11-08 2024-11-30
Registered number: NI704441
VasectomyNI Limited
Unaudited Financial Statements
For the Period 8 November 2023 to 30 November 2024
McCleary & Company Ltd.
Balance Sheet
Registered number: NI704441
30 November 2024
£
Current assets 149,768
Creditors: Amounts Falling Due Within One Year (36,878 )
NET CURRENT ASSETS 112,890
TOTAL ASSETS LESS CURRENT LIABILITIES 112,890
NET ASSETS 112,890
CAPITAL AND RESERVES 112,890

Notes

1. General Information
VasectomyNI Limited is a private company, limited by shares, incorporated in Northern Ireland, registered number NI704441 . The registered office is Quaker Buildings, High Street, Lurgan, Co. Armagh, BT66 8BB.
2. Average Number of Employees
Average number of employees, including directors, during the period was: NIL
-
For the period ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Peter Quinn
Director
26 February 2025